ES2033442T3 - Procedimiento para preparar una composicion farmaceutica a base de acidos grasos. - Google Patents

Procedimiento para preparar una composicion farmaceutica a base de acidos grasos.

Info

Publication number
ES2033442T3
ES2033442T3 ES88311445T ES88311445T ES2033442T3 ES 2033442 T3 ES2033442 T3 ES 2033442T3 ES 88311445 T ES88311445 T ES 88311445T ES 88311445 T ES88311445 T ES 88311445T ES 2033442 T3 ES2033442 T3 ES 2033442T3
Authority
ES
Spain
Prior art keywords
prepare
procedure
pharmaceutical composition
fatty acids
composition based
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88311445T
Other languages
English (en)
Inventor
David Frederick Scoti Horrobin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Efamol Holdings PLC
Original Assignee
Efamol Holdings PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Efamol Holdings PLC filed Critical Efamol Holdings PLC
Application granted granted Critical
Publication of ES2033442T3 publication Critical patent/ES2033442T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Transplantation (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fats And Perfumes (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)

Abstract

COMPOSICION DE UNA CICLOOSPORINA Y GLA O DGL O UN DERIVADO SUYO CONVERTIBLE EN EL CUERPO EN ELLA, SOLOS O EN COMBINACION CON UN DILUYENTE O UN VEHICULO FARMACEUTICO.
ES88311445T 1987-12-14 1988-12-02 Procedimiento para preparar una composicion farmaceutica a base de acidos grasos. Expired - Lifetime ES2033442T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878729153A GB8729153D0 (en) 1987-12-14 1987-12-14 Fatty acid compositions

Publications (1)

Publication Number Publication Date
ES2033442T3 true ES2033442T3 (es) 1996-07-16

Family

ID=10628481

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88311445T Expired - Lifetime ES2033442T3 (es) 1987-12-14 1988-12-02 Procedimiento para preparar una composicion farmaceutica a base de acidos grasos.

Country Status (15)

Country Link
US (1) US4970076A (es)
EP (1) EP0321128B1 (es)
JP (1) JP2722227B2 (es)
KR (1) KR970010542B1 (es)
AT (1) ATE72988T1 (es)
AU (1) AU616713B2 (es)
CA (1) CA1335789C (es)
DE (1) DE3868886D1 (es)
ES (1) ES2033442T3 (es)
GB (1) GB8729153D0 (es)
GR (1) GR3003991T3 (es)
HK (1) HK129593A (es)
IE (1) IE61698B1 (es)
NZ (1) NZ227241A (es)
ZA (1) ZA889269B (es)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4750057A (en) * 1985-12-30 1988-06-07 Eastman Kodak Company De-interlacing circuit for simultaneous readout of paired fields
CH679119A5 (es) * 1988-05-13 1991-12-31 Sandoz Ag
HU201567B (en) * 1988-07-21 1990-11-28 Gyogyszerkutato Intezet Process for production of intravenous medical compositions containing cyclosphorin
GB8823621D0 (en) * 1988-10-07 1988-11-16 Madhok R Compositions containing cyclosporins
JP3070611B2 (ja) * 1989-03-07 2000-07-31 サントリー株式会社 △▲上５▼―不飽和化酵素阻害剤
US5264217A (en) * 1990-01-30 1993-11-23 Efamol Holdings Ltd. Method of increasing the total fat content of milk
GB9111900D0 (en) * 1991-06-03 1991-07-24 Efamol Holdings Fatty acid compositions
SK277092A3 (en) * 1992-09-07 1996-08-07 Galena As Medicaments with n-methylated cyclic undecapeptides
US5716614A (en) * 1994-08-05 1998-02-10 Molecular/Structural Biotechnologies, Inc. Method for delivering active agents to mammalian brains in a complex with eicosapentaenoic acid or docosahexaenoic acid-conjugated polycationic carrier
US5603951A (en) * 1994-11-09 1997-02-18 Hanmi Pharm. Ind. Co., Ltd. Cyclosporin-containing soft capsule compositions
MY118354A (en) 1995-05-01 2004-10-30 Scarista Ltd 1,3-propane diol derivatives as bioactive compounds
USRE40546E1 (en) * 1996-05-01 2008-10-21 Scarista, Ltd. 1,3-Propane diol esters and ethers and methods for their use in drug delivery
EP0823897B1 (en) * 1995-05-01 2004-07-28 Scarista Limited Nicotinic acid esters and pharmaceutical compositions containing them
US6696413B2 (en) 1995-06-16 2004-02-24 Hexal Ag Pharmaceutical preparation with cyclosporin A
US5827822A (en) * 1996-03-25 1998-10-27 Sangstat Medical Corporation Cyclosporin a formulations as nanoparticles
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
US5834017A (en) * 1995-08-25 1998-11-10 Sangstat Medical Corporation Oral cyclopsporin formulations
US5766629A (en) 1995-08-25 1998-06-16 Sangstat Medical Corporation Oral cyclosporin formulations
US20030220234A1 (en) 1998-11-02 2003-11-27 Selvaraj Naicker Deuterated cyclosporine analogs and their use as immunodulating agents
JP4761093B2 (ja) * 1997-12-10 2011-08-31 シクロスポリン セラポイティクス リミテッド オメガ−３脂肪酸油を含む医薬組成物
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
IL143580A0 (en) 1998-12-11 2002-04-21 Pharmasolutions Inc Pharmaceutical compositions containing lipophilic drugs and methods for the preparation thereof
US6057289A (en) * 1999-04-30 2000-05-02 Pharmasolutions, Inc. Pharmaceutical composition comprising cyclosporin in association with a carrier in a self-emulsifying drug delivery system
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
KR100982466B1 (ko) 2001-10-19 2010-09-16 이소테크니카 인코포레이티드 시클로스포린 유사체의 합성
WO2004071510A1 (en) * 2003-02-11 2004-08-26 Cipla Ltd Pharmaceutical composition comprising immunosuppressants for the treatment of dermatophytosis
US20050059583A1 (en) 2003-09-15 2005-03-17 Allergan, Inc. Methods of providing therapeutic effects using cyclosporin components
US7345093B2 (en) * 2004-04-27 2008-03-18 Formatech, Inc. Methods of enhancing solubility of compounds
GB0413729D0 (en) * 2004-06-18 2004-07-21 Tillotts Pharma Ag A pharmaceutical composition and its use
US7151085B2 (en) 2004-11-15 2006-12-19 Allergan, Inc. Therapeutic methods using cyclosporine components
US7135455B2 (en) * 2004-11-15 2006-11-14 Allergan, Inc Methods for the therapeutic use of cyclosporine components
DE102005061409A1 (de) 2005-12-22 2007-06-28 Robert Bosch Gmbh Elektromagnetisch betätigbares Ventil
US20080058418A1 (en) * 2006-09-06 2008-03-06 The Coca-Cola Company Stable polyunsaturated fatty acid emulsions and methods for inhibiting, suppressing, or reducing degradation of polyunsaturated fatty acids in an emulsion
US20090018186A1 (en) * 2006-09-06 2009-01-15 The Coca-Cola Company Stable beverage products comprising polyunsaturated fatty acid emulsions
GB0907413D0 (en) 2009-04-29 2009-06-10 Equateq Ltd Novel methods
US10143652B2 (en) 2009-09-23 2018-12-04 Curirx Inc. Methods for the preparation of liposomes
US9402812B2 (en) * 2009-09-23 2016-08-02 Indu JAVERI Methods for the preparation of liposomes
WO2012125569A2 (en) 2011-03-11 2012-09-20 Beth Israel Deaconess Medical Center, Inc. Anti-cd40 antibodies and uses thereof
US8293790B2 (en) 2011-10-19 2012-10-23 Dignity Sciences Limited Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof
AU2015270418B2 (en) 2014-06-04 2020-08-06 Ds Biopharma Limited Pharmaceutical compositions comprising DGLA and use of same
AU2016315873B2 (en) 2015-09-04 2022-08-18 Primatope Therapeutics Inc. Humanized anti-CD40 antibodies and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4196189A (en) * 1977-03-19 1980-04-01 Blendax-Werke R. Schneider Dental and oral hygiene preparations
AU548156B2 (en) * 1980-02-14 1985-11-28 Novartis Ag Cyclo sporin
DK39683A (da) * 1982-02-08 1983-08-09 Smithkline Beckman Corp Antifungale midler
EP0087865B1 (en) * 1982-03-01 1986-10-01 Efamol Limited Pharmaceutical composition
HU197733B (en) * 1985-05-29 1989-05-29 Chinoin Gyogyszer Es Vegyeszet Process for producing ephedrin-salts of 7-oxo-prosta-cyclin derivatives
US4822606A (en) * 1986-04-07 1989-04-18 Duke University Immunosuppressive synthetic peptides and analogs thereof based on retroviral envelope sequences
AU588695B2 (en) * 1986-05-02 1989-09-21 Brigham And Women's Hospital Omega-3 fatty acid aided reduction of cyclosporin mephrotoxicity

Also Published As

Publication number Publication date
EP0321128A1 (en) 1989-06-21
AU2677888A (en) 1989-06-15
US4970076A (en) 1990-11-13
KR970010542B1 (ko) 1997-06-28
EP0321128B1 (en) 1992-03-04
IE61698B1 (en) 1994-11-16
DE3868886D1 (de) 1992-04-09
AU616713B2 (en) 1991-11-07
ZA889269B (en) 1989-08-30
GB8729153D0 (en) 1988-01-27
GR3003991T3 (es) 1993-03-16
NZ227241A (en) 1991-05-28
KR890009383A (ko) 1989-08-01
ATE72988T1 (de) 1992-03-15
JP2722227B2 (ja) 1998-03-04
IE883626L (en) 1989-06-14
CA1335789C (en) 1995-06-06
JPH0276819A (ja) 1990-03-16
HK129593A (en) 1993-12-03

Similar Documents

Publication Publication Date Title
ES2033442T3 (es) Procedimiento para preparar una composicion farmaceutica a base de acidos grasos.
AU6701890A (en) Process for the production of biologically active protein
DE68909077D1 (de) Gamma-Linolensäure oder Dihomo-gamma-Linolensäure enthaltende Zubereitung zur Verbesserung der Haut.
IT8721453A0 (it) Acidi poliinsaturi ad azione vasocinetica e relative formulazioni farmaceutiche e cosmetiche.
ES2060290T3 (es) Composiciones de acidos grasos esenciales (efa) y terapia.
HK37694A (en) Fatty acids compositions
AU1770888A (en) Treatment of periodontal disease
AU1821888A (en) Treatment or prevention of memory loss using essential fatty acid compositions
ES2033831T3 (es) Una composicion a base de hierro y metodo para el tratamiento del cancer.
DE69108616D1 (de) 3.3'-Dithiobis (Propionsäuren) und Estern davon.
NZ223293A (en) Beta-alkyl melatonins and pharmaceutical compositions
SE8800988L (sv) Farmaceutiska kompositioner med verkan paa hjaertat och det kardiovaskulaera systemet samt foerfarande foer framstaellning av desamma
EP0378824A3 (en) Use of omega-3-fatty acids as anticachexia agents
SE8800989L (sv) Dietkomposition samt foerfarande foer framstaellning av densamma
SE8800990L (sv) Hudregenererande kosmetisk komposition samt foerfarande foer framstaellning av densamma
ATE107648T1 (de) 1-carbacephalosporin-antibiotika.
GR3005231T3 (es)
PT83721B (pt) Processo de preparacao de composicoes farmaceuticas a base de activadores de plasminogenio com actividade trombolitica
DE3856129D1 (de) Alveolare oberflächenaktive proteine
ZA879556B (en) Derivatives on n-(2-alkyl-3-mercapto-glutaryl)alpha-amino acids and their use as collagenase-inhibitors
RO100949B1 (en) Procedure and driving ccircuit for high power bipolar transistors
ATE104966T1 (de) 9-(acylamino)tetrahydroacridinderivate und wahrnehmungssteigernde mittel davon als aktiver wirkstoff.
BR6702135U (pt) Mesa conversivel

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 321128

Country of ref document: ES

FG2A Definitive protection

Ref document number: 0321128

Country of ref document: ES